With the best-selling medication in the world, tirzepatide, and a record-setting $1 trillion valuation to go with it, Eli ...

A global pharmaceutical company is moving into Center City next year — and it could be a “game-changing” development for Philly’s biotech scene, a leader in the space says. “We see it as a ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

Pharmas have a record $1 trillion to deploy on new biotech innovation deals. All they need is for the Federal Reserve to lower rates, according to a new report from Ernst & Young. And that’s a big ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Moleculin Biotech (MBRX) announced it has entered into a research and material transfer agreement with CIC biomaGUNE, a non-profit research ...

The U.S. and U.K. reached a new pharmaceutical pricing agreement to boost innovation, raise U.K. payments for new medicines ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Biotechnology today demands not just domain knowledge but also creativity, ethics, and transdisciplinary thinking, as ...

During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion state-of-the-art pharmaceutical manufacturing plant in Huntsville.